资讯|论坛|病例

搜索

首页 医学论坛 专业文章 医学进展 签约作者 病例中心 快问诊所 爱医培训 医学考试 在线题库 医学会议

您所在的位置:首页 > 心血管内科诊疗指南 > 2008美国先天性心脏病指南

2008美国先天性心脏病指南

2014-06-04 17:26 阅读:2582 来源:爱爱医 责任编辑:张子玲
[导读] It is important that the medical profession play a central rolein critically evaluating the use of diagnostic procedures andtherapies introduced and tested for detection, management, orprevention of disease.

    《2008美国先天性心脏病指南》内容简介:

    It is important that the medical profession play a central rolein critically evaluating the use of diagnostic procedures andtherapies introduced and tested for detection, management, orprevention of disease. Rigorous, expert **ysis of the avail-able data documenting absolute and relative benefits and risksof these procedures and therapies can produce guidelines thatimprove the effectiveness of care, optimize patient outcomes,and favorably affect the cost of care by focusing resources onthe most effective strategies.

    《2008美国先天性心脏病指南》内容预览:

   
The American College of Cardiology Foundation (ACCF)and the American Heart Association (AHA) have jointlyengaged in the production of guidelines in the area ofcardiovascular disease since 1980. The American College ofCardiology (ACC)/AHA Task Force on Practice Guidelinesis charged with developing, updating, and revising practiceguidelines for cardiovascular diseases and procedures anddirects this effort. Writing committees are charged withassessing the evidence as an independent group of authors todevelop, update, or revise recommendations for clinicalpractice.

    Experts in the subject under consideration have beenselected from both organizations to examine subject-specificdata and write guidelines in partnership with representativesfrom other medical practitioner and specialty groups. Writingcommittees are specifically charged to perform a formalliterature review, weigh the strength of evidence for oragainst particular treatments or procedures, and includeestimates of expected health outcomes where data exist.Patient-specific modifiers, comorbidities, and issues of pa-tient preference that might influence the choice of tests ortherapies are considered, as well as the frequency offollow-up and cost-effectiveness. When available, ***rma-tion from studies on cost is considered, but data on efficacyand clinical outcomes constitute the primary basis for recom-mendations in these guidelines.

    点击下载***:《2008美国先天性心脏病指南》


分享到:
  版权声明:

  本站所注明来源为"爱爱医"的文章,版权归作者与本站共同所有,非经授权不得转载。

  本站所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,不希望被转载的媒体或个人可与我们

  联系zlzs@120.net,我们将立即进行删除处理

意见反馈 关于我们 隐私保护 版权声明 友情链接 联系我们

Copyright 2002-2024 Iiyi.Com All Rights Reserved